TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alcidion Group Limited ( (AU:ALC) ) just unveiled an announcement.
Alcidion Group Limited announced the cessation of 449,603 performance rights due to unmet conditions, impacting its issued capital. This development may influence the company’s financial structuring and stakeholder interests, as it reflects on the company’s performance metrics and strategic planning.
The most recent analyst rating on (AU:ALC) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited operates in the healthcare technology industry, providing innovative solutions that enhance clinical workflows and patient care. The company focuses on delivering software and services that improve healthcare delivery and operational efficiency.
Average Trading Volume: 1,392,822
Technical Sentiment Signal: Buy
Current Market Cap: A$147.7M
Learn more about ALC stock on TipRanks’ Stock Analysis page.